Trade Name: Topleucon
Generic Name: Molgramostim (Recombinant Human Granulocyte Macrophage Colony-Stimulating Factor, rHuGM-CSF)
1. National Medical Insurance, Category B.
2. Launched in 1997.
3. The first China-made Molgramostim in market.
4. National standard bulk supplier of Molgramostim.
5.As an important immunomodulator of tumor vaccines, Topleucon
has participated in international clinical research in Europe in recent years.
The relevant research results have been published on international authoritative
tumor research platforms such as American Society of Clinical Oncology (ASCO) Annual Meeting.Indications:
Product description download：Molgramostim.pdf
Tel：86 592 6889105/108
Email： firstname.lastname@example.org / email@example.com
Add：No. 330 Wengjiao Road, Haicang, Xiamen, Fujian, China
Adverse Events Tel：86-592-6889111
Adverse Events Email：firstname.lastname@example.org